Bradmer Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in developing proprietary drugs for the treatment of cancer.
| Email: | info@bradmerpharma.com |
| Main Phone: | +1 416 847-6905 |
| Address: | 365 Bay Street, Wildeboer Dellelce Place |
| Address 2: | Suite 800 |
| State: | ON |
| City / Town: | Toronto |
| Country: | CAN |
| Postal Code: | M5H 2V1 |
| Exchange: | GREY |
| CEO: | Alan M. Ezrin |
| Employees: | 3 |
| NAICS: | Pharmaceutical Preparation Manufacturing (325412) |
| Last Price 0.16 | Change $ 0. | Change % 0.00 | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close 0.16 |
| Last Trade | Volume 0 | 52 Wk Hi 0.16 | 52 Wk Low 0.003 |
| Market Cap 3.1 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 19,659,725.00 | EPS (TTM) -0.02 | PE Ratio N/A | Exchange Greys |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
